Globus Medical Inc Class A (GMED)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$87.60

Buy

$87.77

arrow-up$1.51 (+1.75%)

Prices updated at 01 Apr 2026, 16:15 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.

Income statement

20242025
2,519m2,939m
1,484m1,981m
219m537m
8.7118.28
103m538m
473m814m
Sales, General and administrative981m1,178m
Interest expenses--
Provision for income taxes18m67m
Operating expenses1,264m1,444m
Income before taxes121m605m
Net income available to common shareholders103m538m
0.763.98
Net interest income-4m7m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.753.92
Free cash flow per share2.15924.1347
Book value/share29.612832.5706
Debt equity ratio0.020010.022723

Balance sheet

20242025
Current assets2,177m2,126m
Current liabilities856m498m
Total capital4,177m4,573m
Total debt537m119m
Total equity4,177m4,573m
Total non current liabilities--
Loans--
Total assets5,252m5,303m
Total liabilities--
Cash and cash equivalents784m526m
Common stock137m135m

Cash flow

20242025
Cash at beginning of period467m784m
Cash dividends paid--
405m579m
Investments (gains) losses-176m-355m
784m526m
Net income--
521m753m
-115m-174m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.